Lava Neurovascular Liquid Embolic Agent is iis composed of ethylene vinyl alcohol copolymer (EVOH) dissolved in dimethyl sulphoxide (DMSO) and with (suspended) micronised tantalum powder for radiopacity. This product is aimed to provide an alternative to the conventional adhesive embolic agents that are used for peripheral embolization.

LavaTM Neurovascular Liquid Embolic Agent is iis composed of ethylene vinyl alcohol copolymer (EVOH) dissolved in dimethyl sulphoxide (DMSO) and with (suspended) micronised tantalum powder for radiopacity. This product is aimed to provide an alternative to the conventional adhesive embolic agents that are used for peripheral embolization. The use of adhesive embolic agents in peripheral embolization procedures was associated with several complications, including the detachment of embolic agents from the site of injection and their migration to other regions of the body. This non-adhesive liquid embolic agent overcomes these challenges by providing a safer and more effective method of peripheral embolization.

Ethylene vinyl alcohol copolymer is a biocompatible polymer that is widely used in several medical applications. It has a high degree of stability and is resistant to degradation, which makes it an ideal choice for use in embolic agents. When used in combination with dimethyl sulphoxide, it forms a non-adhesive, liquid embolic agent that can be precisely delivered to the site of embolization. The addition of micronized tantalum powder to this product provides a radiopaque feature that allows clinicians to visualize the location of the embolic agent during the procedure. This ensures that the embolic agent is correctly positioned, and there is no risk of migration to other regions of the body. This non-adhesive liquid embolic agent has several benefits over conventional adhesive agents. Firstly, its non-adhesive nature reduces the risk of complications associated with detachment and migration of embolic agents. Secondly, it provides a more precise method of embolization due to its liquid nature, which allows for better control during injection. Lastly, the use of radiopaque tantalum powder ensures that the embolic agent is correctly positioned and there is no risk of migration.

Non-adhesive liquid embolic agents have a low injection resistance, making them easier to inject and less likely to cause complications such as vessel rupture. Additionally, their non-adhesive nature allows for a smoother and safer removal of the catheter after the procedure.

Non-adhesive liquid embolic agents are available in multiple models with unique low-viscosity formulations such as LAVA-12, LAVA-18, and LAVA-34. These formulations allow for better control during injection, increased precision, and optimal filling of the pathological vessels. Therefore, the diverse range of models and formulations ensures that physicians can tailor their approach to each individual case, thereby increasing the success rate of the procedure.

Lava has improved dispersibility and penetration power. They can penetrate deeper into the pathological vessels, accessing even the microvessels at the far end of the lesion. The improved dispersibility and penetration power also mean that the agent fills any irregularities and crevices within the abnormal vessels, resulting in a more complete occlusion.

Non-adhesive liquid embolic agents are available in multiple models with unique low-viscosity formulations such as LAVA-12, LAVA-18, and LAVA-34. These formulations allow for better control during injection, increased precision, and optimal filling of the pathological vessels. Therefore, the diverse range of models and formulations ensures that physicians can tailor their approach to each individual case, thereby increasing the success rate of the procedure.